Organism name | Cananga odorata |
---|---|
Genus | Cananga |
Family | Annonaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Cananga odorata |
---|---|
Linked NCBI taxonomy ID | 13393 |
Linked level | species |
Family in NCBI taxonomy | Annonaceae |
---|---|
ID | 22140 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Magnoliophyta |
---|---|
ID | 3398 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00027281
![]() |
Anonaine
|
CHEMBL401798
|
C098138
|
1 / 0 / 0 | No. 20 | No. 4 |
![]() |
|
C00025233
![]() |
Coramine
/ Coreximin / Coreximine / (S)-Coreximine / (-)-Coreximine / Coramine(alkaloid) |
CHEMBL1164087
|
No. 37 | No. 4 |
![]() |
|||
C00000620
![]() |
Isoeugenol
|
CHEMBL193598
CHEMBL445206 CHEMBL2135887 |
C036643
|
93 / 36 / 31 | 44 / 1 | No. 310 | No. 6 |
![]() |
C00003203
![]() |
alpha-Ylangene
|
No. 333 | No. 38 |
![]() |
||||
C00001910
![]() |
Reticuline
/ (+)-Reticuline |
CHEMBL235212
CHEMBL401501 CHEMBL464734 |
C003298
|
1 / 0 / 0 | No. 345 | No. 4 |
![]() |
|
C00025334
![]() |
trans-Feruloyltyramine
/ N-trans-Feruloyltyramine / trans-N-Feruloyltyramine |
CHEMBL206555
CHEMBL451720 |
1 / 4 / 2 | No. 499 |
![]() |
|||
C00025258
![]() |
Micheline A
/ (-)-Ushinsunine |
CHEMBL221034
CHEMBL1617041 CHEMBL2009013 |
1 / 0 / 0 | No. 553 |
![]() |
|||
C00025353
![]() |
N-Oxyushinsunine
/ Ushinsunine N-oxide / (-)-Ushinsunine b-N-oxide |
CHEMBL517632
CHEMBL517212 |
No. 553 |
![]() |
||||
C00000165
![]() |
gamma-Eudesmol
|
CHEMBL477900
|
No. 613 | No. 38 |
![]() |
|||
C00047091
![]() |
Sampangine
|
CHEMBL435201
|
1 / 0 / 0 | No. 1472 |
![]() |
|||
C00042398
![]() |
Cleistopholine
|
CHEMBL444067
|
No. 3644 |
![]() |
||||
C00002753
![]() |
Isosafrole
|
CHEMBL487603
|
C015959
|
10 / 6 / 10 | 2 / 0 | No. 3773 |
![]() |
|
C00045958
![]() |
gamma-Eudesmol 11-alpha-L-rhamnoside
/ (-)-gamma-Eudesmol 11-alpha-L-rhamnoside |
CHEMBL477899
|
No. 4164 |
![]() |
||||
C00045716
![]() |
Cananodine
|
CHEMBL476684
|
No. 5427 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000620 C00002753 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000620 C00002753 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000620 C00002753 | 0 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000620 C00001910 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000620 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000620 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000620 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000620 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000620 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000620 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000620 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000620 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002753 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000620 | 2 / 2 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | C00025258 | 0 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00002753 | 1 / 4 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000620 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000620 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000620 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000620 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000620 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000620 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000620 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000620 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000620 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00002753 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000620 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000620 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000620 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000620 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000620 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000620 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000620 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000620 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000620 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000620 | 0 / 0 |
P20701 | Integrin alpha-L | Membrane receptor | C00047091 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000620 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000620 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000620 | 1 / 1 |
Q14761 | Protein tyrosine phosphatase receptor type C-associated protein | Enzyme | C00027281 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000620 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000620 | 1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000620 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000620 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000620 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000620 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000620 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000620 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000620 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000620 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000620 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000620 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000620 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000620 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000620 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000620 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000620 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00000620 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000620 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00002753 | 1 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000620 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000620 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000620 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000620 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00025334 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000620 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000620 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000620 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000620 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000620 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000620 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000620 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000620 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00002753 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000620 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000620 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000620 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000620 | 2 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002753 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000620 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000620 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000620 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000620 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000620 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000620 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000620 | 0 / 3 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000620 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000620 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000620 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000620 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000620 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000620 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000620 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000620 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00002753 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000620 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000620 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000620 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000620 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000620 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000620 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000620 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000620 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002753
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002753
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000620
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000620
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000620
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000620
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00000620
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000620
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000620
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000620
|
10850 | CCL27, ALP, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27 | chemokine (C-C motif) ligand 27 |
C00000620
|
29126 | CD274, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1 | CD274 molecule |
C00000620
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000620
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000620
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000620
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000620
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000620
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000620
|
2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00000620
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000620
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000620
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000620
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000620
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000620
|
7975 | MAFK, NFE2U, P18 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
C00000620
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000620
|
4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00000620
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00000620
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000620
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000620
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000620
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000620
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000620
|
9021 | SOCS3, ATOD4, CIS3, Cish3, SOCS-3, SSI-3, SSI3 | suppressor of cytokine signaling 3 |
C00000620
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000620
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00000620
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00000620
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000620
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000620
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000620
|
10626 | TRIM16, EBBP | tripartite motif containing 16 |
C00000620
|
25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00000620
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000620
|
10587 | TXNRD2, SELZ, TR, TR-BETA, TR3, TRXR2 | thioredoxin reductase 2 (EC:1.8.1.9) |
C00000620
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00000620
|
7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00000620
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
P11308 (related) |
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
Q13315
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00094 | DNA repair defects |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|